Jeesun Lee

Jeesun Lee has a diverse work experience in the medical and pharmaceutical field. Jeesun recently joined Daewoong Pharmaceuticals as the Head of Clinical Development Center in 2022. Prior to this, they worked at Shaperon as a Clinical Development Director from 2021 to 2022, where they played a key role in the Covid 19 pneumonia Phase 2b/3 clinical trial and provided medical insight for drug development plans. Before that, they worked at Pfizer from 2014 to 2021, holding various roles such as Korea Oncology BU Medical Lead and Global Established Pharmaceutical, Medical Manager. Jeesun started their career as a Resident Physician at Seoul National University Hospital and interned at a medical institution in 2009.

Jeesun Lee has a Ph.D in Clinical Epidemiology from Sungkyunkwan University. Additionally, they hold a Master of Public Health (MPH) degree from Seoul National University. Jeesun also studied Medicine at Korea University.